The observed concomitant downregulation of AKT1, ERK1/2, NPAS4, BDNF, and other NPAS4 targets strongly suggests the importance of these pathways in tumor brain, as it manifests in the hippocampus. This evidence concerns the gene AKT1 and neoplasm.